GEMCITABINE\OXALIPLATIN: 80 Adverse Event Reports & Safety Profile
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
80
Total FAERS Reports
16 (20.0%)
Deaths Reported
10
Hospitalizations
80
As Primary/Secondary Suspect
2
Life-Threatening
Active Ingredient: GEMCITABINE HYDROCHLORIDE\OXALIPLATIN ·
First Report: 20110101 · Latest Report: 20250423
What Are the Most Common GEMCITABINE\OXALIPLATIN Side Effects?
#1 Most Reported
Lymphoma
33 reports (41.3%)
#2 Most Reported
Disease progression
21 reports (26.3%)
#3 Most Reported
Off label use
9 reports (11.3%)
All GEMCITABINE\OXALIPLATIN Side Effects by Frequency
| Side Effect | Reports | % of Total | Deaths | Hosp. |
|---|---|---|---|---|
| Lymphoma | 33 | 41.3% | 4 | 3 |
| Disease progression | 21 | 26.3% | 6 | 4 |
| Off label use | 9 | 11.3% | 3 | 2 |
| Platelet count decreased | 8 | 10.0% | 6 | 4 |
| Acute kidney injury | 7 | 8.8% | 7 | 4 |
| Diarrhoea | 7 | 8.8% | 7 | 4 |
| Malignant neoplasm progression | 7 | 8.8% | 1 | 0 |
| Tumour lysis syndrome | 6 | 7.5% | 6 | 4 |
| Vomiting | 6 | 7.5% | 6 | 4 |
| Burkitt's lymphoma | 5 | 6.3% | 5 | 4 |
| Chest discomfort | 5 | 6.3% | 5 | 4 |
| Chest pain | 5 | 6.3% | 5 | 4 |
| Cough | 5 | 6.3% | 5 | 4 |
| Cytomegalovirus infection | 5 | 6.3% | 0 | 0 |
| Epstein-barr virus infection | 5 | 6.3% | 0 | 0 |
| Gastric dilatation | 5 | 6.3% | 5 | 4 |
| Hyperkalaemia | 5 | 6.3% | 5 | 4 |
| Post procedural haemorrhage | 5 | 6.3% | 5 | 4 |
| Restlessness | 5 | 6.3% | 5 | 4 |
| Sepsis | 5 | 6.3% | 5 | 2 |
Who Reports GEMCITABINE\OXALIPLATIN Side Effects? Age & Gender Data
Gender: 46.0% female, 54.0% male. Average age: 55.5 years. Most reports from: DE. View detailed demographics →
Is GEMCITABINE\OXALIPLATIN Getting Safer? Reports by Year
| Year | Reports | Deaths | Hosp. |
|---|---|---|---|
| 2011 | 1 | 0 | 0 |
| 2014 | 1 | 0 | 1 |
| 2016 | 1 | 1 | 1 |
| 2018 | 8 | 5 | 4 |
| 2019 | 2 | 1 | 0 |
| 2020 | 2 | 0 | 0 |
| 2022 | 3 | 1 | 0 |
| 2023 | 1 | 0 | 0 |
| 2024 | 1 | 0 | 1 |
| 2025 | 1 | 0 | 1 |
What Is GEMCITABINE\OXALIPLATIN Used For?
| Indication | Reports |
|---|---|
| Diffuse large b-cell lymphoma | 54 |
Official FDA Label for GEMCITABINE\OXALIPLATIN
Official prescribing information from the FDA-approved drug label.